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Site variables, e.g. staff application ratio
Panel vars, e.g. # of members attending meeting
Application vars, e.g., study design, subject type
Interview or meeting
Speaker role; staff, reviewer, 
non-reviewer member
Speaker characteristics: training, 
demographics, etc.
Speaking turn vars: domain, 
content, evaluation codes
Physician Committee Member: I just try and make sure that 
there’s some scientific basis behind what they’re proposing to do….. 
and then I try and make sure the safety parameter that they’re 
proposing they follow, are appropriate and adequate, and then 
I usually summarize my comments so it’s that it’s generally my 
opinion, and I then hope that someone, the secondary reviewer, or 
other people who have potentially more expertise in the given area 
if I don’t, would have more opinions as well.
Lay Member: “I think generally the idea is to get the 
people that really should not be primary reviewers, to be 
the secondary reviewer. You want lay people, or the, ... you 
know, the pharmacists, or the lawyers, or nurses ... to be the 
secondary reviewers.”
Attorney, Committee Member: “I’m neither a statistician 
nor a physician, or a nurse or anybody who would be able to 
make reasonable sense out of the medical side of things. So I 
figure my main goal there as a lay person is to look at what 
the hell they’re doing and see whether the consent form… 
fairly decides what’s going on and most particularly fairly 
decides whatever risks they’re asking you to undergo.”
Study Questions
a. What issues about applications are the focus of IRB 
attention; e.g., the scientific validity of a protocol, or issues of risk or 
informed consent?
b. How, if at all, do the occupants of different roles (chair, community 
member, attorney, scientific expert, etc.) differ in their assessments and 
discussions of applications?
c. How do IRB members identify problems in applications? What information 
resources do they use and how do they use them?
d. How do IRBs organize the work of application review through 
the use of staff, pre-meeting review and formal meetings?
Reviewer: I read the consent form and I sort of have like a little 
um, game that I play. I imagine that its my mother who’s being 
presented with this consent form, could she understand it? Um, 
you know would I feel like she knew what she was getting into, 
would I feel like she had a good sense of what her risks were, um, 
you know somebody who’s not necessarily educated like us.
Interviewer:  When …[if] the medicine that they’re using is kind of advanced 
do you ever end up using outside sources or...look things up on the internet or 
...books or call the PI? Do you do any of that?
Reviewer: Yeah, I do use the internet a fair amount to figure out what the drugs 
are and what they do. If I don’t understand it,….sometimes I’ve contacted [the 
Chair] occasionally with questions and I’ve contacted PI’s occasionally….but 
you know [I] rely on the...oncologist here to…. be able to answer them.
Reviewer: I think that the science needs to be looked at because, as I’m sure some people have said, 
if the science isn’t valid then any subject who’s in that study is needlessly put at risk because no 
knowledge will be gained from it…I alone, with probably the other physicians, kind of do it, depending 
on where the protocol comes from. So if its an NIH protocol, we do pretty much say yeah, a lot of 
really good minds have already looked at this. It’s been approved. It would not have gotten funding 
if it hasn’t already meant really stringent criteria.
Data Collection
u Transcripts of audio recordings  
 of a single meeting of each of 20  
 IRB panels.
u Interviews with: 1. Panel Chairs
 2. Protocol reviewers
 3. IRB administrators
 4. IRB staff
Early Findings of Interest
• There are a wide variety of ways of organizing the IRB review process
• Medically trained reviewers play a significantly larger and more substantial role in IRB reviews 
than community members
• The work of the IRB staff is highly organized and rule-bound; by contrast, the committee reviews 
are minimally structured and substantively focused.
• Committees appear to spend most of their attention on minimizing risks to subjects and as-
suring the quality of the research, and less time than expected on revising consent form language. 
However members in different roles focus on different issues.
• The overwhelming majority of the discussion takes place between the reviewers of a protocol 
and the chairs, with other members participating only under unusual circumstances.
Sample
Two IRB panel meetings at each of 10 sites. 
Each site will be among the 25 largest medical 
research institutions in the U.S.
Background
Institutional Review Boards (IRBs) are 
the primary organizations designed to 
protect research subjects from harm and 
assure that they participate voluntarily. 
At the same time, many researchers 
feel that they intrude into the research 
process without making research safer.
Goals
• Identify which issues about 
applications are the focus of IRB 
attention; e.g., the scientific validity 
of a protocol, issues of risk, informed 
consent
• Clarify how, if at all, the occupants 
of different roles (chair, community 
member, attorney, scientific expert, 
etc.) differ in their discussion of 
applications
• Describe how IRB members identify 
problems in applications; what 
information resources they use and how 
they use them
• Identify how IRBs organize the work 
of application review through the use 
of staff, pre-meeting review and formal 
meetings
It is possible to conceptualize our preliminary quantitative 
model as a pyramid.  The  pyramid arranges variables from the 
most general organizational data (the way in which the IRB at 
a site is set up) to the most specific data, the textual data from 
the meeting and the interviews. In between are background 
data about the way the particular panel functioned on the 
day we observed, features of the studies being processed, 
whether the data come from an interview or the meeting 
and different types of background features of the speaker. 
The basic design of the quantitative analysis is to model the 
bottom of the pyramid in terms of the variables above.
Data Analysis
Close coding of text, quantitative analysis of the frequency 
of issues discussed, and qualitative analysis of themes.
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